BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Bharat Parenterals Ltd. Share Price

NSE
BSE

NSE : BPLPHARMA

BSE : 541096

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,520.00

High

₹1,568.80

Price Summary

Previous Close ₹1,533.30
Day's Range ₹1,520.00 - ₹1,568.80
Open ₹1,545.00
52 Week Range ₹1,125.70 - ₹1,649.00
Volume 586
Market Cap ₹0.00
Previous Close ₹1,530.00
Day's Range ₹1,480.00 - ₹1,559.95
Open ₹1,559.95
52 Week Range ₹880.25 - ₹1,593.95
Volume 247
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 8.99
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.07
Price/Earning (TTM) 0.00
TTM EPS (₹) -22.35
P/E Ratio 0.00
Book Value(₹) 3.32
PAT Margin (%) -12.80
Face Value (₹) 10.00
ROCE(%) -4.85
Trade Value ( ₹ in Lacs) 3.78
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.07
Price/Earning (TTM) 0.00
TTM EPS (₹) -22.35
P/E Ratio 0.00
Book Value(₹) 3.32
PAT Margin (%) -12.80
Face Value (₹) 10.00
ROCE(%) -4.85

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 943.69 3041.34
Expenses N/A N/A
PBT 133.99 363.15
Operating profit 0.0 0.0
Net profit 100.0 264.54

Shareholding Pattern

Promoters (% Holding)

67.20%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

31.31%

FI/Banks/Insurance (% Holding)

0.01%

Government (% Holding)

0.00%

FII

0.11%

About Bharat Parenterals Ltd.

Founded 1992
Managing Director Bharat Desai
NSE Symbol BPLPHARMA

Latest News

Aug
20
2026
EQUITY Posted on Aug 20th 2026

Bharat Parenterals informs about disclosure

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), Bharat Parenterals has informed that the National Stock Exchange of India vide its Circular No. NSE/CML/75748 dated August 14, 2026, has informed its Members that the equity shares of Bharat Parenterals (Symbol: BPLPHARMA) are permitted to trade and admitted to dealings on the Capital Market Segment of NSE with effect from August 17, 2026. Accordingly, the equity shares of the Company are now permitted to trade and admitted to dealings on NSE under the Permitted to Trade category, in addition to their existing listing on BSE. A copy of the aforementioned NSE Circular No. NSE/CML/75748 dated August 14, 2026 is enclosed for information and records. 
The above information is a part of company's filings submitted to BSE.
Read More
Jun
30
2026
EQUITY Posted on Jun 30th 2026

Bharat Parenterals informs about disclosure

Bharat Parenterals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Desai Shares & Stock.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
4
2026
EQUITY Posted on Sep 4th 2026

Asston Pharmaceuticals informs about SAST updates

Asston Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
4
2026
EQUITY Posted on Sep 4th 2026

Viyash Scientific informs about allotment of equity shares under ESOP

Viyash Scientific has informed that the Nomination and Remuneration Committee of the Company vide resolution passed by circulation on September 04, 2026, has approved the allotment of 6,12,773 equity shares of face value Rs 2 each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as follows: a. 2,30,001 equity shares at an exercise price of Rs 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 3,82,772 equity shares at an exercise price of Rs 101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
4
2026
EQUITY Posted on Sep 4th 2026

Max Healthcare Institute informs about allotment of equity shares

Max Healthcare Institute has informed that Nomination & Remuneration Committee (‘NRC’) of the Company today, September 4, 2026, at 8.52 am (IST), has approved the allotment of 33,765 equity shares having face value of ₹10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute - Employee Stock Option Scheme 2022. Consequent to the above allotment, the paid-up equity share capital of the Company stands increased from 973,27,64,860 to 973,31,02,510. In terms of regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the requisite details of equity shares allotted as above are enclosed as Annexure. This disclosure will also be hosted on Company's website:  www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Bharat Parenterals Ltd. ?

The current share price of Bharat Parenterals Ltd. is ₹1,533.30 as of 2026-09-04.

The market capitalisation of Bharat Parenterals Ltd. is ₹1,057.88 as of 2026-09-03.

The 1-year return of Bharat Parenterals Ltd. is % as of .

The P/E ratio of Bharat Parenterals Ltd. is 0.00 as of 2026-09-04.

The 52-week high and low of Bharat Parenterals Ltd. are ₹1,649.00 and ₹1,125.70, respectively, as of 2026-09-04.

The dividend yield of Bharat Parenterals Ltd. is 0.0651% as of2026-09-03.

You can buy Bharat Parenterals Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Bharat Parenterals Ltd. is Bharat Desai.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore